Cash Flow Statement

Amortizatization of Intangibles Cash from Financing Activities Cash from Operations Change in Accured Expenses Change in Cash Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Other Working Capital Changes Other financing activities Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Ratios

Kairos Pharma (KAPA) Short-Term Debt issuances (2025)

Kairos Pharma's Short-Term Debt issuances history spans 1 years, with the latest figure at $210000.0 for Q2 2025.